Brief: Bionano Labs Expands Clinical Testing Menu With Launch Of OGM-Based LDTs
15/03/2023 12:08
March 15 (Reuters) - Bionano Genomics Inc BNGO.O :
* BIONANO LABORATORIES EXPANDS ITS CLINICAL TESTING MENU
WITH
LAUNCH OF OGM-BASED LABORATORY DEVELOPED TESTS (LDTS) FOR
PRENATAL AND POSTNATAL ANALYSIS
Source text for Eikon: ID:nGNX3KXtly
Further company coverage: BNGO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bionano Genomics
See all newsBionano Genomics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Bionano Genomics Q2 revenue rises on increased clinical adoption
Brief: Bionano Genomics Q2 Revenue USD 8.2 Million
Bionano Genomics, Inc. expected to post a loss of 68 cents a share - Earnings Preview
Bionano Genomics Q1 revenue up 4%, margin improves; to retire convertible debt